Point72 Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,341
| Closed | -$166K | – | 1425 |
|
|
2024
Q3 | $166K | Buy |
+15,341
| New | +$166K | ﹤0.01% | 1092 |
|
|
2024
Q1 | – | Sell |
-416,020
| Closed | -$8.43M | – | 1578 |
|
|
2023
Q4 | $8.43M | Sell |
416,020
-37,356
| -8% | -$757K | 0.02% | 607 |
|
|
2023
Q3 | $5.77M | Buy |
453,376
+82,489
| +22% | +$1.05M | 0.02% | 683 |
|
|
2023
Q2 | $6.7M | Buy |
370,887
+161,987
| +78% | +$2.93M | 0.02% | 606 |
|
|
2023
Q1 | $3.59M | Buy |
208,900
+69,600
| +50% | +$1.2M | 0.01% | 726 |
|
|
2022
Q4 | $3.09M | Sell |
139,300
-159,700
| -53% | -$3.55M | 0.01% | 710 |
|
|
2022
Q3 | $2.4M | Buy |
+299,000
| New | +$2.4M | 0.01% | 746 |
|